Home
Diseases
Lung Cancer
Clinical Trials

Clinical Trials Related to Lung Cancer

Related studies linked through entity extraction aliases.

Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).

Status: COMPLETED
Phase: PHASE2

Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images

Status: TERMINATED
Phase: N/A

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE3

Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) With LAP Protector

Status: UNKNOWN
Phase: N/A

First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer

Status: UNKNOWN
Phase: PHASE2

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Status: TERMINATED
Phase: N/A

Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors

Status: UNKNOWN
Phase: N/A

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

Status: TERMINATED
Phase: EARLY_PHASE1

Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer

Status: UNKNOWN
Phase: N/A

Virtual Bronchoscopy Transbronchial Needle Aspiration(TBNA): a Proof of Concept Study

Status: TERMINATED
Phase: N/A

Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors

Status: COMPLETED
Phase: PHASE2

Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors

Status: TERMINATED
Phase: N/A

Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)

Status: COMPLETED
Phase: PHASE1

MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy

Status: COMPLETED
Phase: PHASE1/PHASE2

Lung Cancer Exercise Training Study

Status: COMPLETED
Phase: NA

Stanford Accelerated Recovery Trial (START)

Status: TERMINATED
Phase: PHASE3

Fentanyl Matrix in Lung Cancer Pain

Status: COMPLETED
Phase: PHASE4

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

Status: COMPLETED
Phase: PHASE2

Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue

Status: UNKNOWN
Phase: N/A

Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2